Press releases
- Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
- Dexcom Reports First Quarter 2024 Financial Results
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
More ▼
Key statistics
As of last trade Dexcom Inc (DC4:STU) traded at 117.52, -10.60% below its 52-week high of 131.46, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 115.60 |
---|---|
High | 117.52 |
Low | 115.60 |
Bid | 117.18 |
Offer | 117.46 |
Previous close | 116.18 |
Average volume | 104.44 |
---|---|
Shares outstanding | 397.68m |
Free float | 396.22m |
P/E (TTM) | 83.96 |
Market cap | 50.66bn USD |
EPS (TTM) | 1.52 USD |
Data delayed at least 15 minutes, as of May 28 2024.
More ▼